nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2D6—Parkinson's disease	0.91	1	CbGaD
Efavirenz—CYP2B6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000156	0.00172	CbGpPWpGaD
Efavirenz—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000146	0.00162	CbGpPWpGaD
Efavirenz—CYP2B6—Biological oxidations—GSTM1—Parkinson's disease	0.000145	0.00161	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000145	0.0016	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000144	0.0016	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000144	0.00159	CbGpPWpGaD
Efavirenz—CYP2B6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000143	0.00158	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000143	0.00158	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000142	0.00157	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000142	0.00157	CbGpPWpGaD
Efavirenz—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000135	0.00149	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000133	0.00147	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000132	0.00146	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000132	0.00146	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000131	0.00145	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00013	0.00144	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000129	0.00142	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000128	0.00142	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000123	0.00136	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000122	0.00135	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000121	0.00133	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.00012	0.00133	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000119	0.00132	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000119	0.00132	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000118	0.00131	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000118	0.0013	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000113	0.00125	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000111	0.00123	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.00011	0.00122	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.00011	0.00121	CbGpPWpGaD
Efavirenz—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.00011	0.00121	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000109	0.00121	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000109	0.00121	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000109	0.0012	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000109	0.0012	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000109	0.0012	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000108	0.0012	CbGpPWpGaD
Efavirenz—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000108	0.0012	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000108	0.00119	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000107	0.00119	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000103	0.00114	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ND3—Parkinson's disease	0.000103	0.00114	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MCCC1—Parkinson's disease	0.000103	0.00114	CbGpPWpGaD
Efavirenz—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000101	0.00112	CbGpPWpGaD
Efavirenz—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	9.99e-05	0.00111	CbGpPWpGaD
Efavirenz—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	9.94e-05	0.0011	CbGpPWpGaD
Efavirenz—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	9.86e-05	0.00109	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TALDO1—Parkinson's disease	9.67e-05	0.00107	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—OMD—Parkinson's disease	9.67e-05	0.00107	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	9.51e-05	0.00105	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	9.38e-05	0.00104	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—COMT—Parkinson's disease	9.34e-05	0.00103	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	9.34e-05	0.00103	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	9.34e-05	0.00103	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	9.29e-05	0.00103	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	9.27e-05	0.00103	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	9.21e-05	0.00102	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	9.17e-05	0.00101	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	9.17e-05	0.00101	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GCH1—Parkinson's disease	8.75e-05	0.000968	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	8.7e-05	0.000963	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.58e-05	0.000949	CbGpPWpGaD
Efavirenz—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	8.54e-05	0.000945	CbGpPWpGaD
Efavirenz—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	8.42e-05	0.000932	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.25e-05	0.000914	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GBA—Parkinson's disease	7.79e-05	0.000863	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—FBP1—Parkinson's disease	7.79e-05	0.000863	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—DBH—Parkinson's disease	7.79e-05	0.000863	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MCCC1—Parkinson's disease	7.77e-05	0.00086	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ND3—Parkinson's disease	7.77e-05	0.00086	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.53e-05	0.000833	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—OMD—Parkinson's disease	7.31e-05	0.000809	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TALDO1—Parkinson's disease	7.31e-05	0.000809	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—COMT—Parkinson's disease	7.21e-05	0.000798	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	7.17e-05	0.000794	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	7.16e-05	0.000792	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ND3—Parkinson's disease	7.15e-05	0.000791	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MCCC1—Parkinson's disease	7.15e-05	0.000791	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	7.11e-05	0.000787	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MCCC1—Parkinson's disease	7.09e-05	0.000784	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ND3—Parkinson's disease	7.09e-05	0.000784	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	7.07e-05	0.000783	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	6.93e-05	0.000767	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TALDO1—Parkinson's disease	6.72e-05	0.000744	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—OMD—Parkinson's disease	6.72e-05	0.000744	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TALDO1—Parkinson's disease	6.66e-05	0.000737	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—OMD—Parkinson's disease	6.66e-05	0.000737	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GCH1—Parkinson's disease	6.61e-05	0.000731	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.59e-05	0.00073	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	6.5e-05	0.00072	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	6.43e-05	0.000712	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.37e-05	0.000705	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	6.32e-05	0.000699	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.08e-05	0.000673	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ND3—Parkinson's disease	6.06e-05	0.00067	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MCCC1—Parkinson's disease	6.06e-05	0.00067	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GCH1—Parkinson's disease	6.03e-05	0.000667	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.96e-05	0.00066	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GBA—Parkinson's disease	5.89e-05	0.000652	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—DBH—Parkinson's disease	5.89e-05	0.000652	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—FBP1—Parkinson's disease	5.89e-05	0.000652	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—DDC—Parkinson's disease	5.72e-05	0.000633	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—OMD—Parkinson's disease	5.69e-05	0.00063	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TALDO1—Parkinson's disease	5.69e-05	0.00063	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.44e-05	0.000602	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GBA—Parkinson's disease	5.42e-05	0.0006	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—DBH—Parkinson's disease	5.42e-05	0.0006	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.42e-05	0.0006	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTA4—Parkinson's disease	5.4e-05	0.000598	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	5.4e-05	0.000597	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—FBP1—Parkinson's disease	5.37e-05	0.000594	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—DBH—Parkinson's disease	5.37e-05	0.000594	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GBA—Parkinson's disease	5.37e-05	0.000594	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GCH1—Parkinson's disease	5.15e-05	0.00057	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	4.86e-05	0.000538	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MAOB—Parkinson's disease	4.82e-05	0.000533	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ND3—Parkinson's disease	4.67e-05	0.000517	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.67e-05	0.000517	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.64e-05	0.000514	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GBA—Parkinson's disease	4.59e-05	0.000508	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—DBH—Parkinson's disease	4.59e-05	0.000508	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—FBP1—Parkinson's disease	4.59e-05	0.000508	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—OMD—Parkinson's disease	4.39e-05	0.000486	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.39e-05	0.000486	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—DDC—Parkinson's disease	4.32e-05	0.000478	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.17e-05	0.000461	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTA4—Parkinson's disease	4.08e-05	0.000452	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.03e-05	0.000446	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—DDC—Parkinson's disease	3.98e-05	0.00044	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.97e-05	0.00044	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—DDC—Parkinson's disease	3.94e-05	0.000436	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.76e-05	0.000416	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTA4—Parkinson's disease	3.72e-05	0.000412	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	3.68e-05	0.000407	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.68e-05	0.000407	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MAOB—Parkinson's disease	3.64e-05	0.000403	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	3.58e-05	0.000396	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GBA—Parkinson's disease	3.54e-05	0.000392	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—DBH—Parkinson's disease	3.54e-05	0.000392	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.54e-05	0.000392	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CTGF—Parkinson's disease	3.51e-05	0.000389	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.46e-05	0.000383	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.38e-05	0.000374	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—DDC—Parkinson's disease	3.37e-05	0.000373	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.35e-05	0.000371	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.35e-05	0.00037	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.32e-05	0.000367	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	3.27e-05	0.000362	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NQO1—Parkinson's disease	3.24e-05	0.000358	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—TH—Parkinson's disease	3.19e-05	0.000353	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTA4—Parkinson's disease	3.18e-05	0.000352	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.16e-05	0.00035	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.14e-05	0.000348	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYCS—Parkinson's disease	3.06e-05	0.000339	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.86e-05	0.000317	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.84e-05	0.000314	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—COMT—Parkinson's disease	2.71e-05	0.0003	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.7e-05	0.000299	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTP1—Parkinson's disease	2.7e-05	0.000299	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.7e-05	0.000299	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MAOA—Parkinson's disease	2.69e-05	0.000298	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMOX1—Parkinson's disease	2.66e-05	0.000295	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.65e-05	0.000294	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—DDC—Parkinson's disease	2.6e-05	0.000288	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCB1—Parkinson's disease	2.56e-05	0.000283	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—Parkinson's disease	2.48e-05	0.000275	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	2.47e-05	0.000274	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.47e-05	0.000273	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.46e-05	0.000272	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NQO1—Parkinson's disease	2.45e-05	0.000271	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.44e-05	0.00027	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.42e-05	0.000268	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—TH—Parkinson's disease	2.41e-05	0.000267	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPX1—Parkinson's disease	2.38e-05	0.000263	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.31e-05	0.000256	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.28e-05	0.000252	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.26e-05	0.00025	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.25e-05	0.000249	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.23e-05	0.000247	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—TH—Parkinson's disease	2.22e-05	0.000245	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.21e-05	0.000245	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—TH—Parkinson's disease	2.2e-05	0.000243	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—Parkinson's disease	2.19e-05	0.000243	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.19e-05	0.000242	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.13e-05	0.000236	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.11e-05	0.000234	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2.11e-05	0.000233	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CTGF—Parkinson's disease	2.07e-05	0.000229	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—COMT—Parkinson's disease	2.05e-05	0.000227	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOE—Parkinson's disease	2.04e-05	0.000226	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.04e-05	0.000226	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.04e-05	0.000225	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.01e-05	0.000223	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.93e-05	0.000214	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.93e-05	0.000213	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.91e-05	0.000211	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—COMT—Parkinson's disease	1.89e-05	0.000209	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—TH—Parkinson's disease	1.88e-05	0.000208	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.88e-05	0.000208	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.87e-05	0.000207	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.87e-05	0.000207	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—COMT—Parkinson's disease	1.87e-05	0.000207	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.86e-05	0.000206	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.86e-05	0.000205	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.85e-05	0.000205	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.83e-05	0.000203	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.8e-05	0.0002	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.8e-05	0.000199	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.78e-05	0.000197	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.76e-05	0.000195	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—INS—Parkinson's disease	1.74e-05	0.000193	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.72e-05	0.000191	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.71e-05	0.000189	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.66e-05	0.000183	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.65e-05	0.000183	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.64e-05	0.000181	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.63e-05	0.00018	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—COMT—Parkinson's disease	1.6e-05	0.000177	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.6e-05	0.000177	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.59e-05	0.000176	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.59e-05	0.000176	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.57e-05	0.000173	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOE—Parkinson's disease	1.54e-05	0.000171	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.52e-05	0.000169	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.51e-05	0.000167	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.5e-05	0.000167	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.49e-05	0.000165	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.47e-05	0.000163	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.46e-05	0.000162	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TH—Parkinson's disease	1.45e-05	0.00016	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOE—Parkinson's disease	1.42e-05	0.000157	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOE—Parkinson's disease	1.41e-05	0.000156	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.4e-05	0.000155	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.39e-05	0.000154	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—INS—Parkinson's disease	1.32e-05	0.000146	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.29e-05	0.000143	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—COMT—Parkinson's disease	1.23e-05	0.000136	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.23e-05	0.000136	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.22e-05	0.000135	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—INS—Parkinson's disease	1.21e-05	0.000134	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.21e-05	0.000134	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOE—Parkinson's disease	1.2e-05	0.000133	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—INS—Parkinson's disease	1.2e-05	0.000133	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.16e-05	0.000129	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.13e-05	0.000125	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.08e-05	0.000119	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—INS—Parkinson's disease	1.03e-05	0.000114	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—Parkinson's disease	9.96e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOE—Parkinson's disease	9.27e-06	0.000103	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—INS—Parkinson's disease	7.92e-06	8.77e-05	CbGpPWpGaD
